Lung Clean
Natural health product licensed in Canada
- Other names
- Lung Cleanser
- Licence holder
- Mapleland Biotech Corporation
- NPN or DIN-HM
- 80132607
- Status
- Active licence
- Licence date
- 17 July 2024
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Hyssopus officinalis L.: L'huile essentielle de cette plante est interdite.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Hyssopus officinalis Source : Hyssopus officinalis - Sommité (herbe) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,200 mg | 120 mg | Not calculated |
| Thymus vulgaris Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 800 mg | 100 mg | Not calculated |
| Trigonella foenum-graecum Source : Trigonella foenum-graecum - Graine Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 800 mg | 100 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 50 mg | 150,000 µg |
| Zingiber officinale Source : Zingiber officinale - Rhizome Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 400 mg | 50 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose microcristalline, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Zingiber officinale is traditionally used in Herbal Medicine as an expectorant and cough suppressant antitussive to help relieve bronchitis as well as coughs and colds. Hyssopus officinalis is traditionally used in Herbal Medicine as an expectorant to help relieve excess mucous of the upper respiratory passages (anticatarrhal). Helps to maintain/support immune function/the immune system. Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Thymus vulgaris is traditionally used in Herbal Medicine as an expectorant to help relieve the symptoms of bronchitis and mucus buildup of the upper respiratory tract (anti-catarrh). Trigonella foenum-graecum is traditionally used in Herbal Medicine as an expectorant to help relieve excess mucous of the upper respiratory passages (anticatarrhal).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80132607
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.